{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:27:14Z","timestamp":1786591634114,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10072-026-09250-7","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:32:47Z","timestamp":1784770367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumefactive demyelinating disorders as neoplasm mimics: description of a typical case and literature review"],"prefix":"10.1007","volume":"47","author":[{"given":"Yinuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-2364","authenticated-orcid":false,"given":"Ru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"9250_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple Sclerosis. Lancet 391:1622\u20131636. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1","journal-title":"Lancet"},{"key":"9250_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/jnnp-2012-304498","volume":"84","author":"TA Hardy","year":"2013","unstructured":"Hardy TA, Chataway J (2013) Tumefactive Demyelination: An Approach to Diagnosis and Management. J Neurol Neurosurg Psychiatry 84:1047\u20131053. https:\/\/doi.org\/10.1136\/jnnp-2012-304498","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9250_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-025-02863-3","author":"\u00d6 Kizek","year":"2025","unstructured":"Kizek \u00d6, Emekli AS, G\u00fcnd\u00fcz T, K\u00fcrt\u00fcnc\u00fc M, Eraksoy M (2025) Cerebral Tumefactive Demyelinating Lesions: Clinical Spectrum, Long-Term Outcomes, and Treatment. Acta Neurol Belg. https:\/\/doi.org\/10.1007\/s13760-025-02863-3","journal-title":"Acta Neurol Belg"},{"key":"9250_CR4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awn098","volume":"131","author":"CF Lucchinetti","year":"2008","unstructured":"Lucchinetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW, Weigand S, Thomsen K, Mandrekar J, Altintas A, Erickson BJ, Konig F, Giannini C, Lassmann H, Linbo L, Pittock SJ, Bruck W (2008) Clinical and Radiographic Spectrum of Pathologically Confirmed Tumefactive Multiple Sclerosis. Brain 131:1759\u20131775. https:\/\/doi.org\/10.1093\/brain\/awn098","journal-title":"Brain"},{"key":"9250_CR5","doi-asserted-by":"publisher","DOI":"10.5137\/1019-5149.JTN.10920-14.0","author":"X Ning","year":"2014","unstructured":"Ning X, Zhao C, Wang C, Zhang D, Luo Q (2014) Intracranial Demyelinating Pseudotumor: A Case Report and Review of the Literature. Turkish Neurosurg. https:\/\/doi.org\/10.5137\/1019-5149.JTN.10920-14.0","journal-title":"Turkish Neurosurg"},{"key":"9250_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.msard.2017.04.003","volume":"14","author":"H Algahtani","year":"2017","unstructured":"Algahtani H, Shirah B, Alassiri A (2017) Tumefactive Demyelinating Lesions: A Comprehensive Review. Multiple Scler Relat Disorders 14:72\u201379. https:\/\/doi.org\/10.1016\/j.msard.2017.04.003","journal-title":"Multiple Scler Relat Disorders"},{"key":"9250_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/13524585251371984","author":"HH Zhao-Fleming","year":"2025","unstructured":"Zhao-Fleming HH, Decker PA, Kosel ML, Drucker KL, Kollmeyer T, Lachance DH, Clarkson BD, Howe CL, Jenkins R, Tobin WO, Eckel-Passow J (2025) Genomewide association study of a homogeneous multiple sclerosis cohort: tumefactive demyelination. Mult Scler. https:\/\/doi.org\/10.1177\/13524585251371984","journal-title":"Mult Scler"},{"key":"9250_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.msard.2018.12.022","volume":"28","author":"P Codjia","year":"2019","unstructured":"Codjia P, Ayrignac X, Carra-Dalliere C, Cohen M, Charif M, Lippi A, Collongues N, Corti L, De Seze J, Lebrun C, Vukusic S, Durand-Dubief F, Labauge P (2019) Multiple sclerosis with atypical MRI presentation: results of a nationwide multicenter study in 57 consecutive cases. Mult Scler Relat Disord 28:109\u2013116. https:\/\/doi.org\/10.1016\/j.msard.2018.12.022","journal-title":"Mult Scler Relat Disord"},{"key":"9250_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000566","volume":"6","author":"C Lapucci","year":"2019","unstructured":"Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L (2019) Different MRI patterns in MS worsening after stopping fingolimod. Neurol Neuroimmunol Neuroinflamm 6:e566. https:\/\/doi.org\/10.1212\/NXI.0000000000000566","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9250_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395749","volume":"15","author":"N Rabaneda-Lombarte","year":"2024","unstructured":"Rabaneda-Lombarte N, Teniente-Serra A, Massuet-Vilamaj\u00f3 A, Ramo-Tello C, Presas-Rodr\u00edguez S (2024) Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers. Front Immunol 15:1395749. https:\/\/doi.org\/10.3389\/fimmu.2024.1395749","journal-title":"Front Immunol"},{"key":"9250_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/WCO.0000000000000683","volume":"32","author":"TA Hardy","year":"2019","unstructured":"Hardy TA (2019) Pseudotumoral Demyelinating Lesions: Diagnostic Approach and Long-Term Outcome. Curr Opin Neurol 32:467\u2013474. https:\/\/doi.org\/10.1097\/WCO.0000000000000683","journal-title":"Curr Opin Neurol"},{"key":"9250_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/WNL.0b013e31820c30c1","volume":"76","author":"C Vilari\u00f1o-G\u00fcell","year":"2011","unstructured":"Vilari\u00f1o-G\u00fcell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, Lyons KE, Uitti RJ, Wszolek ZK, Dickson DW, Farrer MJ, Ross OA (2011) MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 76:670\u2013672. https:\/\/doi.org\/10.1212\/WNL.0b013e31820c30c1","journal-title":"Neurology"},{"key":"9250_CR13","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1007\/s00415-020-10296-6","volume":"267","author":"SM Lazzarin","year":"2020","unstructured":"Lazzarin SM, Cannizzaro M, Russo T, Sangalli F, Callea M, Colombo B, Moiola L, Filippi M (2020) Successful Treatment of HIV-Associated Tumefactive Demyelinating Lesions with Corticosteroids and Cyclophosphamide: A Case Report. J Neurol 267:3773\u20133775. https:\/\/doi.org\/10.1007\/s00415-020-10296-6","journal-title":"J Neurol"},{"issue":"6","key":"9250_CR14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.4103\/0028-3886.273654","volume":"67","author":"D Plantone","year":"2019","unstructured":"Plantone D, Piantadosi C, Ruggieri S, Anelli V, Koudriavtseva T (2019) Tumefactive demyelinating lesions and pregnancy. Neurol India 67:1519. https:\/\/doi.org\/10.4103\/0028-3886.273654","journal-title":"Neurol India"},{"key":"9250_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1052678","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Miao X, Wang Y, Sun J, Gao H, Han J, Li Y, Wang Q, Sun C, Liu J (2022) Central nervous system tumefactive demyelinating lesions: risk factors of relapse and follow-up observations. Front Immunol 13:1052678. https:\/\/doi.org\/10.3389\/fimmu.2022.1052678","journal-title":"Front Immunol"},{"key":"9250_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8409247","volume":"2018","author":"O Ekmekci","year":"2018","unstructured":"Ekmekci O, Eraslan C (2018) Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome. Case Rep Neurol Med 2018:1\u20135. https:\/\/doi.org\/10.1155\/2018\/8409247","journal-title":"Case Rep Neurol Med"},{"key":"9250_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2214\/AJR.20.23226","volume":"217","author":"M Nakayama","year":"2021","unstructured":"Nakayama M, Naganawa S, Ouyang M, Jones KA, Kim J, Capizzano AA, Moritani T (2021) A Review of Clinical and Imaging Findings in Tumefactive Demyelination. Am J Roentgenol 217:186\u2013197. https:\/\/doi.org\/10.2214\/AJR.20.23226","journal-title":"Am J Roentgenol"},{"key":"9250_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jns.2015.12.039","volume":"361","author":"P Preziosa","year":"2016","unstructured":"Preziosa P, Martinelli V, Moiola L, Radaelli M, Gerevini S, Guidetti D, Immovilli P, Michieletti E, Scagnelli P, Comola M, Rocca MA, Filippi M, Comi G (2016) Dynamic Pattern of Clinical and MRI Findings in a Tumefactive Demyelinating Lesion: A Case Report. J Neurol Sci 361:184\u2013186. https:\/\/doi.org\/10.1016\/j.jns.2015.12.039","journal-title":"J Neurol Sci"},{"key":"9250_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neurol.2019.08.008","volume":"176","author":"S Navardi","year":"2020","unstructured":"Navardi S, Sahraian MA, Naser Moghadasi A (2020) Tumefactive Demyelinating Lesions after Initiating Fingolimod in Patient with Multiple Sclerosis: A Case Report. Rev Neurol 176:289\u2013290. https:\/\/doi.org\/10.1016\/j.neurol.2019.08.008","journal-title":"Rev Neurol"},{"key":"9250_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104992","volume":"79","author":"SH Chew","year":"2023","unstructured":"Chew SH, Achmad Sankala HB, Chew E, Md Arif MHB, Mohd Zain NR, Hashim H, Koya Kutty SB, Chee YC, Mohd Saleh NB, Ong BH, Viswanathan S (2023) Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study. Mult Scler Relat Disord 79:104992. https:\/\/doi.org\/10.1016\/j.msard.2023.104992","journal-title":"Mult Scler Relat Disord"},{"key":"9250_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3174\/ajnr.A2871","volume":"33","author":"CH Toh","year":"2012","unstructured":"Toh CH, Wei K-C, Ng S-H, Wan Y-L, Castillo M, Lin C-P (2012) Differentiation of Tumefactive Demyelinating Lesions from High-Grade Gliomas with the Use of Diffusion Tensor Imaging. AJNR Am J Neuroradiol 33:846\u2013851. https:\/\/doi.org\/10.3174\/ajnr.A2871","journal-title":"AJNR Am J Neuroradiol"},{"key":"9250_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194669","volume":"20","author":"G Treglia","year":"2019","unstructured":"Treglia G, Muoio B, Trevisi G, Mattoli MV, Albano D, Bertagna F, Giovanella L (2019) Diagnostic performance and prognostic value of PET\/CT with different tracers for brain tumors: a systematic review of published meta-analyses. Int J Mol Sci 20:4669. https:\/\/doi.org\/10.3390\/ijms20194669","journal-title":"Int J Mol Sci"},{"key":"9250_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, La Foug\u00e8re C, Langen K-J, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn J-C, Weller M (2019) Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging 46:540\u2013557. https:\/\/doi.org\/10.1007\/s00259-018-4207-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9250_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.nicl.2016.12.020","volume":"13","author":"N Galldiks","year":"2017","unstructured":"Galldiks N, Law I, Pope WB, Arbizu J, Langen K-J (2017) The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. Neuroimage Clin 13:386\u2013394. https:\/\/doi.org\/10.1016\/j.nicl.2016.12.020","journal-title":"Neuroimage Clin"},{"key":"9250_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2017.08.005","volume":"381","author":"P S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez P, Meca-Lallana V, Barbosa A, Manzanares R, Palm\u00ed I, Vivancos J (2017) Tumefactive demyelinating lesions of 15 patients: clinico-radiological features, management and review of the literature. J Neurol Sci 381:32\u201338. https:\/\/doi.org\/10.1016\/j.jns.2017.08.005","journal-title":"J Neurol Sci"},{"key":"9250_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12883-025-04495-9","volume":"25","author":"R Jaki","year":"2025","unstructured":"Jaki R, Al-Frejat Z, Bitar Z (2025) Tumefactive Demyelinating Lesions: A Case Report and Literature Review. BMC Neurol 25:475. https:\/\/doi.org\/10.1186\/s12883-025-04495-9","journal-title":"BMC Neurol"},{"key":"9250_CR27","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, Arrambide G, Moccia M, Pia Amato M, Amezcua L, Banwell B, Bar-Or A, Barkhof F, Butzkueven H, Ciccarelli O, Chataway J, Cohen JA, Comi G, Correale J, Deisenhammer F, Filippi M, Fiol J, Freedman MS, Fujihara K, Granziera C, Green AJ, Hartung H-P, Hellwig K, Kappos L, Kimbrough D, Killestein J, Lublin F, Marignier R, Marrie RA, Miller A, Otero-Romero S, Ontaneda D, Ramanathan S, Reich D, Rocca MA, Rovira \u00c0, Saidha S, Salter A, Sastre-Garriga J, Saylor D, Solomon AJ, Sormani MP, Stankoff B, Tintore M, Tremlett H, Van der Walt A, Viswanathan S, Wiendl H, Wildemann B, Yamout B, Zaratin P, Calabresi PA, Coetzee T, Thompson AJ (2025) Diagnosis of Multiple Sclerosis: 2024 Revisions of the McDonald Criteria. Lancet Neurol 24:850\u2013865. https:\/\/doi.org\/10.1016\/S1474-4422(25)00270-4","journal-title":"Lancet Neurol"},{"key":"9250_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA (2016) Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73:1297. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2549","journal-title":"JAMA Neurol"},{"key":"9250_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s10072-019-04197-4","volume":"41","author":"T Ueno","year":"2020","unstructured":"Ueno T, Kinoshita I, Arai A, Suzuki C, Tomiyama M (2020) Combined Central and Peripheral Demyelination with Tumefactive Demyelinating Lesions in the Brainstem and Longitudinally Extensive Optic Neuritis: A Case Report. Neurol Sci 41:1601\u20131603. https:\/\/doi.org\/10.1007\/s10072-019-04197-4","journal-title":"Neurol Sci"},{"key":"9250_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211006503","volume":"14","author":"AG Vakrakou","year":"2021","unstructured":"Vakrakou AG, Tzanetakos D, Evangelopoulos M-E, Argyrakos T, Tzartos JS, Anagnostouli M, Andreadou E, Koutsis G, Velonakis G, Toulas P, Gialafos E, Dimitrakopoulos A, Psimenou E, Stefanis L, Kilidireas C (2021) Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases. Ther Adv Neurol Disord 14:17562864211006503. https:\/\/doi.org\/10.1177\/17562864211006503","journal-title":"Ther Adv Neurol Disord"},{"key":"9250_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020444","volume":"20","author":"G Ferrara","year":"2019","unstructured":"Ferrara G, Petrillo MG, Giani T, Marrani E, Filippeschi C, Oranges T, Simonini G, Cimaz R (2019) Clinical use and molecular action of corticosteroids in the pediatric age. Int J Mol Sci 20:444. https:\/\/doi.org\/10.3390\/ijms20020444","journal-title":"Int J Mol Sci"},{"key":"9250_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejpn.2025.03.005","volume":"55","author":"A Selek","year":"2025","unstructured":"Selek A, G\u00f6cmen R, G\u00fcnbey C, Konu\u015fkan B, Oncel I, Anlar B (2025) Tumefactive Demyelinating Lesions in Children. Eur J Pediatr Neurol 55:33\u201337. https:\/\/doi.org\/10.1016\/j.ejpn.2025.03.005","journal-title":"Eur J Pediatr Neurol"},{"key":"9250_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.msard.2018.07.001","volume":"25","author":"P S\u00e1nchez","year":"2018","unstructured":"S\u00e1nchez P, Meca-Lallana V, Vivancos J (2018) Tumefactive Multiple Sclerosis Lesions Associated with Fingolimod Treatment: Report of 5 Cases. Multiple Scler Relat Disorders 25:95\u201398. https:\/\/doi.org\/10.1016\/j.msard.2018.07.001","journal-title":"Multiple Scler Relat Disorders"},{"key":"9250_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.106168","volume":"92","author":"O Tamas","year":"2024","unstructured":"Tamas O, Kovacevic M, Veselinovic N, Budimkic M, Jovicevic V, Momcilovic N, Drulovic J, Mesaros S (2024) Etiology and characteristics of pseudotumoral lesions and tumefactive demyelination in multiple sclerosis. Mult Scler Relat Disord 92:106168. https:\/\/doi.org\/10.1016\/j.msard.2024.106168","journal-title":"Mult Scler Relat Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09250-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09250-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09250-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:40:06Z","timestamp":1786588806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09250-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9250"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09250-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare there are no competing financial or non-financial interests that could be perceived to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"653"}}